EMA
approval
· 2015-09-25
New treatment option for patients with rare blood cancer
Summary
EMA announces a new treatment option for patients with a rare blood cancer, indicating a new therapy has been authorized or recommended for use in this indicati…
Upgrade for the full analysis, importance score, and drug timeline.